Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ...
The European Patent Office last week upheld one of Moderna’s key patents, handing the biotech an important victory in its ...
The RSV shot — the first ever drug using mRNA technology approved for a disease other than COVID — gives it another ...
The Cambridge biotech said Friday that the European Patent Office has upheld the validity of one of its key patents, a ...
The government’s push to fund the development of an mRNA bird flu vaccine comes amid an H5N1 outbreak in cattle and poultry ...
The Biden administration is close to signing an agreement with Moderna (NASDAQ:MRNA) to fund a late-stage trial for the ...
The jury found that AstraZeneca's Tagrisso violated Pfizer's Wyeth unit's patent rights under US patents 10,603,314 and ...
In December 2023, the EPO invalidated the ‘565 patent which protects respiratory virus vaccines. Litigation over the patents ...
The Food and Drug Administration approved Moderna's RSV vaccine to prevent lower respiratory tract disease in adults aged 60 or older ...
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the ...
Moderna said that the European Patent Office had decided to maintain the validity of one of the company's key patents ...
London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and ...